UK Report Urges Better Medicine Supply Risk Management

A new report emphasizes the critical need for enhanced early warning systems to mitigate medicine supply disruptions in the UK, particularly for generic drugs. Recommendations include strengthening reporting mechanisms and improving data sharing between industry and the NHS. Leveraging AI for better collaborative planning is also suggested to protect patients from potential shortages.